Sentence: Utilizing this data , we suggest that nivolumab plus ipilimumab and cabozantinib may be favored for first-line treatment of specific populations of older patients .
Drug combination annotation:
[{'class': 'POS', 'spans': ['nivolumab', 'ipilimumab', 'cabozantinib'], 'is_context_needed': False}]